(Q34720361)

English

Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60-2770, are not dependent on endogenous nitric oxide or reduced heme

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60-2770, are not dependent on endogenous nitric oxide or reduced heme (English)

1 reference

Europe PubMed Central

4 August 2017

Johannes-Peter Stasch

5

object named as

Johannes-Peter Stasch

1 reference

Europe PubMed Central

4 August 2017

Philip J. Kadowitz

8

object named as

Philip J Kadowitz

1 reference

Europe PubMed Central

4 August 2017

7

object named as

Bobby D Nossaman

1 reference

Europe PubMed Central

4 August 2017

Subramanyam N Murthy

6

object named as

Subramanyam N Murthy

1 reference

Europe PubMed Central

4 August 2017

Edward A Pankey

1

object named as

Edward A Pankey

1 reference

Europe PubMed Central

4 August 2017

Adeleke M Badejo

3

object named as

Adeleke M Badejo

1 reference

Europe PubMed Central

4 August 2017

author name string

Manish Bhartiya

2

1 reference

Europe PubMed Central

4 August 2017

Umair Haider

4

1 reference

Europe PubMed Central

4 August 2017

publication date

7 January 2011

1 reference

Europe PubMed Central

4 August 2017

American Journal of Physiology Heart and Circulatory Physiology

1 reference

Europe PubMed Central

4 August 2017

300

1 reference

Europe PubMed Central

4 August 2017

3

1 reference

Europe PubMed Central

4 August 2017

H792-802

1 reference

Europe PubMed Central

4 August 2017

Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase stimulator, BAY 41-8543, are modulated by nitric oxide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

Kynurenine is an endothelium-derived relaxing factor produced during inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

Population pharmacokinetics and pharmacodynamics of cinaciguat, a soluble guanylate cyclase activator, in patients with acute decompensated heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

NO- and haem-independent soluble guanylate cyclase activators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

Cardiovascular actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vivo studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

Inhibition of soluble guanylate cyclase by ODQ.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

A molecular basis for nitric oxide sensing by soluble guanylate cyclase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

Effects of thiols, sugars, and proteins on nitric oxide activation of guanylate cyclase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064306

7 July 2018

Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00953.2010

21 January 2018

Inhibition by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) of responses to nitric oxide-donors in rat pulmonary artery: influence of the mechanism of nitric oxide generation.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00953.2010

21 January 2018

Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00953.2010

21 January 2018

Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00953.2010

21 January 2018

Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass

1 reference

https://pubmed.ncbi.nlm.nih.gov/21217076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21217076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/21217076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Requirement for heme in the activation of purified guanylate cyclase by nitric oxide

1 reference

https://pubmed.ncbi.nlm.nih.gov/21217076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical

1 reference

https://pubmed.ncbi.nlm.nih.gov/21217076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states

1 reference

https://pubmed.ncbi.nlm.nih.gov/21217076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide

1 reference

https://pubmed.ncbi.nlm.nih.gov/21217076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase

1 reference

https://pubmed.ncbi.nlm.nih.gov/21217076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1152/AJPHEART.00953.2010

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34720361&oldid=2110591979"